Tag: affymetrix

January 3, 2018

ChroMedX Corp. Executes Definitive Agreement with DxEconomix to Lead Value-Based Transactions

ChroMedX Corp. (CSE:CHX) (OTC:CHXIF) (FSE: EIY2), (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to report...
November 27, 2017

ChroMedX Accepts Proposal; Signs LOI with Diagnostic Marketing Experts to Conduct a Value-Based Transaction for the HemoPalm Blood Analyzer System

ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company“), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 24, 2017

ChroMedX Agrees Have DxEconmix Promote HemoPalm

ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company“), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 30, 2016

Is the Stem Cell Market Heating Up? Acquisition Activity Suggests Yes.

Stem cell research seems to be heating up—a hypothesis further evidenced by 2016's acquisition activity.
May 10, 2016

Technavio Expects the Global Biochips Market to Exceed USD 13 Billion by 2020

LONDON–(BUSINESS WIRE)–According to the latest market study released by Technavio, the global biochips market is expected to exceed USD 13...
September 8, 2015

Genetics Study Might Hold the Key to Predicting Alzheimer’s

A study published in Genome Biology discovered a signature of healthy ageing that could help detect Alzheimer's disease decades prior...